Catalyst Wire Dossier Catalyst Wire Dossier

Cabaletta

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cabaletta, covering 2016-11-22 to 2017-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients [Phase 2]

See pricing